Mineralys Therapeutics (MLYS) grants CMO 102,400 RSUs and 135,000 options
Rhea-AI Filing Summary
Mineralys Therapeutics, Inc. reported that Chief Medical Officer James J. Ferguson III received equity-based compensation on 2026-08-10. He was granted 102,400 shares of common stock in the form of Restricted Stock Units (RSUs), vesting in four equal annual installments starting on the first anniversary of the grant date. He also received a stock option for 135,000 shares of common stock at an exercise price of $27.38 per share, vesting 25% on the first anniversary and the remainder in 36 substantially equal monthly installments, and expiring on 2036-08-10. Following these awards, his reported direct holdings related to these grants are 102,400 common shares and options for 135,000 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 102,400 shares
Net Buy
2 txns
Insider
Ferguson James J. III
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F2 | 135,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 102,400 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 135,000 shares (Direct);
Common Stock — 102,400 shares (Direct)
Footnotes (2)
- F1. Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash consideration, each of which represents a contingent right to receive one share of common stock upon vesting. The RSUs vest in annual installments over a period of four years, with 1/4th of the total shares underlying the RSU vesting on each one-year anniversary of the date of grant.
- F2. The stock option vests as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
Key Figures
RSUs granted: 102,400 shares
Options granted: 135,000 shares
Option exercise price: $27.38 per share
+3 more
6 metrics
RSUs granted
102,400 shares
Restricted Stock Units of common stock granted on 2026-08-10
Options granted
135,000 shares
Stock option for common stock granted on 2026-08-10
Option exercise price
$27.38 per share
Exercise price of the 135,000-share stock option
Option expiration
2036-08-10
Expiration date of the 135,000-share stock option
Common stock holdings after RSU grant
102,400 shares
Direct common stock position reported following RSU grant
Option holdings after grant
135,000 shares
Direct option position reported following option grant
Key Terms
Restricted Stock Units (RSUs), vesting, exercise price, substantially equal monthly installments
4 terms
Restricted Stock Units (RSUs) financial
"Restricted Stock Units (RSUs) are granted to the reporting person for no additional cash"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
vesting financial
"The RSUs vest in annual installments over a period of four years, with 1/4th"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price": "27.3800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
substantially equal monthly installments financial
"remaining shares vesting in 36 substantially equal monthly installments thereafter."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What equity awards did MLYS Chief Medical Officer James J. Ferguson III receive on 2026-08-10?
James J. Ferguson III received 102,400 RSUs of common stock and a stock option for 135,000 shares at an exercise price of $27.38 per share as part of his equity compensation.
How do the 102,400 RSUs granted to the MLYS Chief Medical Officer vest?
The 102,400 RSUs vest over four years, with 1/4 of the shares vesting on each one-year anniversary of the grant date, contingent on the vesting conditions described in the award.
Were the MLYS equity awards to the Chief Medical Officer granted for cash consideration?
The RSUs were granted for no additional cash consideration, each representing a contingent right to receive one share of common stock upon vesting; the stock option has an exercise price of $27.38 per share when exercised.
What is the expiration date of the MLYS stock option granted to the Chief Medical Officer?
The stock option granted to James J. Ferguson III for 135,000 shares of Mineralys Therapeutics common stock carries an expiration date of 2036-08-10, subject to the vesting and other plan terms.